Raymond James & Associates Decreases Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Raymond James & Associates lowered its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) by 2.2% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 68,606 shares of the company’s stock after selling 1,539 shares during the quarter. Raymond James & Associates owned about 0.08% of Acadia Healthcare worth $5,364,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the company. AE Wealth Management LLC boosted its holdings in Acadia Healthcare by 3.3% in the 3rd quarter. AE Wealth Management LLC now owns 9,476 shares of the company’s stock worth $741,000 after acquiring an additional 299 shares during the period. Raymond James Financial Services Advisors Inc. boosted its holdings in Acadia Healthcare by 21.8% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 39,487 shares of the company’s stock worth $3,087,000 after acquiring an additional 7,074 shares during the period. Louisiana State Employees Retirement System purchased a new position in Acadia Healthcare in the 3rd quarter worth approximately $1,892,000. Bailard Inc. purchased a new position in Acadia Healthcare in the 3rd quarter worth approximately $203,000. Finally, National Bank of Canada FI purchased a new position in Acadia Healthcare in the 3rd quarter worth approximately $205,000. Hedge funds and other institutional investors own 99.79% of the company’s stock.

Acadia Healthcare Stock Performance

ACHC stock opened at $86.00 on Monday. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 0.50. The firm has a market cap of $7.82 billion, a P/E ratio of 27.74, a P/E/G ratio of 2.00 and a beta of 1.26. Acadia Healthcare Company, Inc. has a 12-month low of $50.07 and a 12-month high of $89.85. The stock’s 50 day simple moving average is $83.46 and its 200 day simple moving average is $81.17.

Acadia Healthcare (NASDAQ:ACHC – Get Rating) last issued its earnings results on Monday, October 31st. The company reported $0.80 earnings per share for the quarter, hitting the consensus estimate of $0.80. Acadia Healthcare had a return on equity of 10.34% and a net margin of 11.16%. The firm had revenue of $666.73 million for the quarter, compared to analyst estimates of $656.66 million. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.08 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Royal Bank of Canada decreased their price target on Acadia Healthcare from $94.00 to $93.00 and set an “outperform” rating for the company in a report on Monday, December 12th. Loop Capital upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the company from $90.00 to $95.00 in a research note on Monday, December 12th. UBS Group reduced their target price on Acadia Healthcare to $96.00 in a research note on Friday, November 4th. StockNews.com initiated coverage on Acadia Healthcare in a research note on Wednesday, October 12th. They set a “hold” rating for the company. Finally, Stephens increased their target price on Acadia Healthcare from $86.00 to $88.00 and gave the company an “equal weight” rating in a research note on Thursday, December 8th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $89.90.

About Acadia Healthcare

(Get Rating)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.